Low Dose Naltrexone (LDN)
LDN is a derivative of the drug Naltrexone, which was originally developed in the 1960s as an opioid antagonist. Naltrexone is a powerful medication that works by blocking the receptors in the brain that are responsible for the effects of opioids. When taken at higher doses, naltrexone can be effective in treating addiction to opioids, but it can also cause significant side effects such as nausea, vomiting, and fatigue.
Low Dose Naltrexone (LDN) is currently under study in patients with various types of chronic pain. Several cancers, and autoimmune disorders are also being studied. While these studies are underway, it is used widely.
Naltrexone is a prescription medication that is typically used to treat addiction, specifically opioid addiction. It works by blocking the effects of opioids in the brain, which can help to reduce cravings and prevent relapse in individuals with addiction. However, Low Dose Naltrexone (LDN) has also been explored for use in the treatment of various conditions such as multiple sclerosis, Crohn's disease, and fibromyalgia.
LDN is a much lower dose of naltrexone, typically ranging from 1.5 to 4.5 mg per day. This lower dose is thought to be more tolerable and have fewer side effects, while still providing some of the benefits of the higher dose. LDN is typically taken orally in the form of a pill or a liquid.
One of the main ways in which LDN is thought to be helpful is in the treatment of addiction. When taken at higher doses, naltrexone has been shown to be effective in reducing cravings and preventing relapse in individuals with addiction to opioids, alcohol, and other substances. LDN is thought to have a similar effect at lower doses, although the evidence for its use in addiction treatment is somewhat limited.
Low Dose Naltrexone for Chronic Pain
LDN has been explored for its potential use in the treatment of various medical conditions. For example, it has been suggested that LDN may be helpful in the treatment of multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system. Some studies have suggested that LDN may help to reduce inflammation and improve symptoms in people with MS, although the evidence is mixed and more research is needed.
LDN has also been studied for its potential use in the treatment of Crohn's disease, a chronic inflammatory bowel disease that affects the digestive system. Some studies have suggested that LDN may help to reduce inflammation and improve symptoms in people with Crohn's disease, although the evidence is limited and more research is needed.
LDN has also been explored as a potential treatment for fibromyalgia, a chronic pain disorder that is characterized by widespread musculoskeletal pain and fatigue. Some studies have suggested that LDN may help to reduce pain and improve quality of life in people with fibromyalgia, although the evidence is mixed and more research is needed.
Low Dose Naltrexone (LDN) is currently under study in patients with various types of chronic pain including migraines, fibromyalgia, and neuropathy. Other chronic pain states, various types of cancers, and autoimmune related disorders are also being studied. While these studies are underway, it is used widely.
Low Dose Naltrexone for Autoimmune Diseases
What we are providing
This is the text area for a paragraph describing this service. You may want to give examples of the service and who may be able to benefit from it. This is the text area for a paragraph describing this service. You may want to give examples of the service and who may be able to benefit from it.
What People Say About Us
